Register Interest for BVP's 2025 EIIS Fund - Avail of 1% free top up if you invest before 28th November (Fund Opening October 2025) Click Here

Telenostic are committed to developing next-generation devices that lead the way for the future of the industry.

OvaCyte is Telenostics inaugural parasitology diagnostic technology. A breakthough parasite egg recovery and identification platform. OvaCyte introduces a novel intestinal parasite analysis technology at the point of care, bringing efficiency, convenience, and cost effective diagnostics to the veterinarian.

This is an EIIS Fund Investment